Synergy with the CMIC Group capabilities
The CMIC Group, comprising 28 companies and over 7,500 employees globally, provides integrated support across the pharmaceutical value chain. Building on its foundation as non-clinical CRO, SMO, CDMO, and CSO, the Group also extends its capabilities into broader healthcare solutions through the PHVC（Personal Health Value Creator）business model.
CMIC’s CRO business combines strong execution through collaboration with SMOs and group healthcare companies with a group CRO network across 12 Asian countries (see list of our group companies), centered in Japan. Leveraging regional regulatory and cultural expertise, we support global clinical development and maximize product value from the clinical stage onward.
- CRO
(Contract Research Organization) - Comprehensive support for research and development of disease prevention and treatment
- SMO
(Site Management Organization) - Comprehensive support of medical institutes and medical staff
- CDMO
(Contract Development & Manufacturing Organization) - Development and manufacturing support for pharmaceutical products and biopharmaceutical API from clinical to commercial
- CSO
(Contract Sales Organization) - Medical, sales and marketing support for pharmaceuticals, and orphan drugs development to commercialization
- Healthcare Solutions
- Support individuals, local governments, etc. with solutions using a new ecosystem of healthcare